The National Institutes of Health Clinical Center in Bethesda,
Maryland, has begun the phase 1 clinical trial for testing the
effectiveness and safety of a monoclonal antibody against malaria,
enrolling healthy adult volunteers. Its the first time mAb CIS43LS is
being tested in humans. The trial will be carried out in 73 volunteers
aged between […]
The post First Human Trial Of Monoclonal Antibody Against Malaria Is
Underway appeared first on BioTecNika .
https://www.biotecnika.org/2020/01/first-clinical-trial-of-malaria-antibody-to-be-conducted-in-73-volunteers/
Biotech News
No comments:
Post a Comment